Dimension Capital, a venture firm based in New York, has raised $500 million for its second fund. This comes just two years after the launch of its first fund.
The firm is focused on life sciences and technology and aims to take advantage of the growing trends in artificial intelligence and innovative drug development approaches. With this significant capital infusion, Dimension plans to invest in startups that use technology to improve the search for new medicines.
The firm's commitment to advancing the intersection of AI and healthcare demonstrates its belief in the transformative potential of these sectors.